Form 4 for IMVT Immunovant, Inc.
Accepted 2021-11-09 00:00:00 ET · period of report 2021-11-05 · accession 0001764013-21-000121 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-09 | 2021-11-05 | IMVT | Macias William L. | Chief Medical Off | A - Grant | $0.00 | +112.1K | 224.2K | +100% | $0 |
| D | 2021-11-09 | 2021-11-05 | IMVT | Macias William L. | Chief Medical Off | A - Grant | $0.00 | +167.3K | 167.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-05 | A | A | 112,108 | $0.00 | 224,153 | D | — | — | (F1) Represents the number of shares underlying restricted stock units awards ("RSUs"). (F2) The RSUs vest in their entirety on January 1, 2023, subject to the Reporting Person providing continuous service to the Issuer as of such date. |
| 2 | Derivative | Stock Option (right to buy) | 2021-11-05 | A | A | 167,325 | $0.00 | 167,325 | D | $8.58 · — to 2031-11-05 | 167,325 Common Stock | (F3) Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on October 25, 2022 and the remainder of the shares underlying the options vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date. |